Atlas Trials

Multiple Myeloma Refractory

49 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Multiple Myeloma Refractory

RecordFirmDate
A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma (NCT05121103)Epizyme, Inc.2022-05-31
Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies (NCT05191472)Alfred Chung, MD2022-05-03
APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma (NCT04657861)Zhejiang University2022-05-03
Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma (NCT05008536)Xinqiao Hospital of Chongqing2021-10-01
Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma (NCT04861480)Chongqing Precision Biotech Co., Ltd2021-06-16
A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients (NCT04688853)Gadeta B.V.2021-05-13
Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells (NCT04813653)Tel-Aviv Sourasky Medical Center2021-04-18
CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies (NCT04603872)Zhejiang University2020-11-01
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma (NCT04287855)Poitiers University Hospital2020-08-28
A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM. (NCT04414475)Karyopharm Therapeutics Inc2020-07-01
Alvocade® (Bortezomib) Safety and Effectiveness Study (NCT06012383)NanoAlvand2016-07-01
Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT02176213)Ajai Chari2014-06-01

Track Multiple Myeloma Refractory automatically

Every clearance here is in the API, with alerts when new ones post.